Skip to content

In the BioHarmony Drug Report Database

Norelgestromin

Ortho Evra, Evra (norelgestromin) is a small molecule pharmaceutical. Norelgestromin was first approved as Ortho Evra on 2001-11-20. It is used to treat amenorrhea and uterine hemorrhage in the USA. It has been approved in Europe to treat contraception. It is known to target short transient receptor potential channel 3 and short transient receptor potential channel 6.
Trade Name Evra
Common Name Norelgestromin
Indication amenorrhea, contraception, uterine hemorrhage
Drug Class Estrogens; progestins
Norelgestromin
Get full access now